AGITG 2013* Niall Tebbutt
Austin Health, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Reporting PTEN status in advanced colorectal cancer, time for standardisation? (#5)
12:45 PM
Christopher Hocking
Poster Review
A PHASE IB STUDY OF SECOND-LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN METASTATIC COLORECTAL CANCER (mCRC) WITH KRAS WILD TYPE (WT) (#22)
12:45 PM
Amanda Townsend
Poster Review
Meta-analysis of overall survival impact of biological therapy in relapsed metastatic colorectal cancer (#20)
12:45 PM
Eva Segelov
Poster Review
ATTAX3: A randomised phase II study evaluating weekly docetaxel,cisplatin, fluoropyrimidine (wTCF) plus or minus panitumumab inadvanced oesophago-gastric cancer. (10528)
10:00 AM
Niall Tebbutt
Advanced Upper GI Cancer Session 1